# CORRESP — Clearmind Medicine Inc.  (CMND)  (CIK 0001892500)

> <strong>Clearmind Medicine Inc.  (CMND)  (CIK 0001892500) → SEC staff</strong> · filed 2025-12-08 · ticker CMND · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001213900-25-119141
- **Form:** CORRESP
- **Filer:** Clearmind Medicine Inc.  (CMND)  (CIK 0001892500)
- **CIK:** 0001892500
- **Ticker:** CMND
- **Filed:** 2025-12-08
- **SIC industry:** 2834
- **HQ:** Vancouver, British Columbia, Z4

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1892500/000121390025119141/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1892500&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for Clearmind Medicine Inc.  (CMND)  (CIK 0001892500)

- CORRESP — 2026-05-06 — /comment-letter/0001213900-26-052700
- UPLOAD — 2026-05-06 — /comment-letter/0000000000-26-004625
- CORRESP — 2025-09-30 — /comment-letter/0001213900-25-093593
- UPLOAD — 2025-09-24 — /comment-letter/0000000000-25-010438

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Clearmind Medicine Inc.  (CMND)  (CIK 0001892500) (CIK 0001892500), filed 2025-12-08, accession 0001213900-25-119141. Retrieved via MORVS 2026-11-04 from https://api.morvs.ai/comment-letter/0001213900-25-119141.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*